West Pharma opens 165,000-sq-ft Dublin expansion for high-volume injectable therapies

West Pharmaceutical Services, Inc.

WST

0.00

West Pharmaceutical Services opened a new 165,000-square-foot building at its Damastown site in Dublin to expand contract services capacity.
Expansion targets higher-volume injectable therapies, including diabetes, obesity, and next-generation GLP-1 treatments.
Facility adds advanced automation and commercial-scale drug-handling capabilities beyond component molding, device assembly, and packaging.
Project expands West Vantage contract services offering to support faster development and commercialization for pharma and biotech customers.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. West Pharmaceutical Services Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202603311146PR_NEWS_USPR_____NE22521) on March 31, 2026, and is solely responsible for the information contained therein.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.